LMAT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LMAT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. LeMaitre Vascular's Free Cash Flow for the three months ended in Sep. 2024 was $12.6 Mil. LeMaitre Vascular's Revenue for the three months ended in Sep. 2024 was $54.8 Mil. Therefore, LeMaitre Vascular's FCF Margin % for the quarter that ended in Sep. 2024 was 22.94%.
As of today, LeMaitre Vascular's current FCF Yield % is 1.62%.
The historical rank and industry rank for LeMaitre Vascular's FCF Margin % or its related term are showing as below:
During the past 13 years, the highest FCF Margin % of LeMaitre Vascular was 24.60%. The lowest was 6.08%. And the median was 15.41%.
The historical data trend for LeMaitre Vascular's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LeMaitre Vascular Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
FCF Margin % | Get a 7-Day Free Trial |
![]() |
![]() |
24.60 | 19.57 | 13.70 | 15.24 | - |
LeMaitre Vascular Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
FCF Margin % | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
19.37 | 6.92 | 13.87 | 22.94 | - |
For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's FCF Margin % distribution charts can be found below:
* The bar in red indicates where LeMaitre Vascular's FCF Margin % falls into.
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
LeMaitre Vascular's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
FCF Margin | = | Free Cash Flow (A: Dec. 2023 ) | / | Revenue (A: Dec. 2023 ) |
= | 29.486 | / | 193.484 | |
= | 15.24 % |
LeMaitre Vascular's FCF Margin for the quarter that ended in Sep. 2024 is calculated as
FCF Margin | = | Free Cash Flow (Q: Sep. 2024 ) | / | Revenue (Q: Sep. 2024 ) |
= | 12.576 | / | 54.819 | |
= | 22.94 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of LeMaitre Vascular's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Lawrence J Jasinski | director | SOTEIRA INC., 14 TECH CIRCLE, NATICK MA 01760 |
Bridget A Ross | director | C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747 |
Martha Shadan | director | 9201 W BROADWAY AVE, #650, MINNEAPOLIS MN 55445 |
David B Roberts | director, officer: CFO and Director | 55 BRADFORD STREET, NEEDHAM MA 02492 |
Trent G Kamke | officer: Senior V. P., Operations | 61 WILLOWDEAN AVENUE, WEST ROXBURY MA 02132 |
George W Lemaitre | director, 10 percent owner, officer: Chairman, President and CEO | 342 BUNKER HILL STREET, #2B, CHARLESTOWN MA 02129 |
John A Roush | director | C/O GSI GROUP INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730-1409 |
Pellegrino Joseph P Jr | officer: Executive V.P. Finance | 68 BEACON STREET, BOSTON MA 02108 |
Michael H Thomas | director | P.O. BOX 2207, NOKOMIS FL 34274-2207 |
Peter R Gebauer | officer: President, International OP | AM WALDFELD 17, BAD SODEN 2M 65812 |
Michael T Wijas | officer: VP of Sales, The Americas | C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON MA 01803 |
Lemaitre Cornelia W | director, officer: V.P., Human Resources,Director | 8 SUNSET ROCK ROAD, ANDOVER MA 01810 |
Russell D Hays | director | C/O BIOSOURCE INTERNATIONAL INC, 542 FLYNN RD, CAMARILLO CA 93012 |
Robert V Linden | officer: VP, North American Sales | 236 WOODEN BRIDGE ROAD, HOLLAND PA 18966 |
Thorndike William N Jr | director | HOUSATONIC PARTNERS, 800 BOYLSTON STREET, SUITE 2220, BOSTON MA 02199 |
From GuruFocus
By GlobeNewswire • 11-01-2024
By GuruFocus News • 10-31-2024
By GuruFocus News • 10-09-2024
By GuruFocus News • 11-01-2024
By Marketwired • 11-01-2024
By GuruFocus News • 01-27-2025
By GuruFocus News • 10-10-2024
By GuruFocus Research • 05-08-2024
By GlobeNewswire • 07-16-2024
By Marketwired • 07-16-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.